.png)
AndrewJohnson
- Following sharp gains in the morning hours, INmune Bio (NASDAQ:INMB) fell ~11% during the afternoon session on Friday after the Alzheimer’s drug developer announced an equity offering to raise millions of dollars.
- The Boca Raton, Florida-headquartered biotech, which has nearly 44% of its
English (US) ·